All In MedTech

Device Trial Radar · NCT04754347

Computer Aided Detection of Polyps in Colonoscopy

Randomized, Controlled Trial of a Computer Aided Detection Device in Standard Colonoscopy

Last checked: Nov 19, 2026Latest source record: Dec 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,472 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,472

Actual

Start

Jan 22, 2021

Primary completion

Oct 31, 2021

Study completion Oct 31, 2021

Sponsor

Lead sponsor
Iterative Scopes, IncNot on our public-company list
Sponsor type
Industry
Collaborators
University of Minnesota
First posted
Feb 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to evaluate the clinical benefit and safety of using a computer aided detection device, Skout, for real-time polyp detection in colonoscopy procedures with the indication of screening or surveillance. One of the reasons for the development of interval colorectal cancers is polyps missed during colonoscopy. Our hypothesis is that with the aid of Skout, the adenomas detected per colonoscopy will increase, and it is plausible to believe that this increase in detection could reduce the incidence of interval cancers.

Conditions

  • Colorectal Polyp

Interventions

  • Computer Aided Detection deviceDevice

    The Computer Aided Detection device, Skout, is designed to help endoscopists detect potential colorectal polyps during colonoscopies. The system performs automated real-time analysis on endoscopic video data to identify potential polyps and produces an informational visual aid around the appropriate sections of the video frames on a display monitor.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adenomas per colonoscopyTime frame: At the end of the procedure, 1 day
  2. Positive predictive valueTime frame: At the end of the procedure, 1 day

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Boston Medical Center

    Boston, Massachusetts

  • Mount Auburn Hospital

    Cambridge, Massachusetts

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.